These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 18962846

  • 21. Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.
    Fleming GF, Brunetto VL, Cella D, Look KY, Reid GC, Munkarah AR, Kline R, Burger RA, Goodman A, Burks RT.
    J Clin Oncol; 2004 Jun 01; 22(11):2159-66. PubMed ID: 15169803
    [Abstract] [Full Text] [Related]

  • 22. Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients.
    Bruzzone M, Miglietta L, Franzone P, Gadducci A, Boccardo F.
    Gynecol Oncol; 2004 May 01; 93(2):345-52. PubMed ID: 15099944
    [Abstract] [Full Text] [Related]

  • 23. Phase I trial of taxol as a radiation sensitizer with cisplatin in advanced cervical cancer.
    Chen MD, Paley PJ, Potish RA, Twiggs LB.
    Gynecol Oncol; 1997 Nov 01; 67(2):131-6. PubMed ID: 9367695
    [Abstract] [Full Text] [Related]

  • 24. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.
    Randall ME, Filiaci VL, Muss H, Spirtos NM, Mannel RS, Fowler J, Thigpen JT, Benda JA, Gynecologic Oncology Group Study.
    J Clin Oncol; 2006 Jan 01; 24(1):36-44. PubMed ID: 16330675
    [Abstract] [Full Text] [Related]

  • 25. Paclitaxel, carboplatin and pegylated liposomal doxorubicin in ovarian and peritoneal carcinoma: a phase I study of the Gynecologic Oncology Group.
    Rose PG, Greer BE, Horowitz IR, Markman M, Fusco N.
    Gynecol Oncol; 2007 Jan 01; 104(1):114-9. PubMed ID: 16959305
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC).
    Fields AL, Einstein MH, Novetsky AP, Gebb J, Goldberg GL.
    Gynecol Oncol; 2008 Jan 01; 108(1):201-6. PubMed ID: 17997145
    [Abstract] [Full Text] [Related]

  • 29. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study.
    Susumu N, Sagae S, Udagawa Y, Niwa K, Kuramoto H, Satoh S, Kudo R, Japanese Gynecologic Oncology Group.
    Gynecol Oncol; 2008 Jan 01; 108(1):226-33. PubMed ID: 17996926
    [Abstract] [Full Text] [Related]

  • 30. [A feasibility study of doxorubicin/cisplatin (AP) for postoperative chemotherapy in patients with advanced endometrial cancer].
    Nishio S, Katsumata N, Tanabe H, Matsumoto K, Yonemori K, Kouno T, Shimizu C, Ando M, Fujiwara Y.
    Gan To Kagaku Ryoho; 2006 Nov 01; 33(11):1589-93. PubMed ID: 17108724
    [Abstract] [Full Text] [Related]

  • 31. Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer: results of Cancer and Leukemia Group B 99811.
    Kelly WK, Halabi S, Elfiky A, Ou SS, Bogart J, Zelefsky M, Small E, Cancer Leukemia Group B.
    Cancer; 2008 Dec 01; 113(11):3137-45. PubMed ID: 18989865
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911.
    Langer CJ, Harris J, Horwitz EM, Nicolaou N, Kies M, Curran W, Wong S, Ang K.
    J Clin Oncol; 2007 Oct 20; 25(30):4800-5. PubMed ID: 17947728
    [Abstract] [Full Text] [Related]

  • 34. Phase I trial of concomitant vinorelbine, paclitaxel, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies.
    Mundt AJ, Rotmensch J, Waggoner SE, Yamada D, Langhauser C, Fleming GF.
    Gynecol Oncol; 2001 Aug 20; 82(2):333-7. PubMed ID: 11531289
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A phase I study of paclitaxel, cisplatin, and fluorouracil (TCF) for advanced gastric cancer.
    Hara T, Omura K, Hirano M, Asada Y, Munemoto Y, Sakamoto J.
    Cancer Chemother Pharmacol; 2007 Apr 20; 59(5):631-6. PubMed ID: 16924496
    [Abstract] [Full Text] [Related]

  • 40. concomitant chemoradiotherapy with mitomycin C and cisplatin in advanced unresectable carcinoma of the head and neck: phase I-II clinical study.
    Strojan P, Karner K, Smid L, Soba E, Fajdiga I, Jancar B, Anicin A, Budihna M, Zakotnik B.
    Int J Radiat Oncol Biol Phys; 2008 Oct 01; 72(2):365-72. PubMed ID: 18394816
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.